KOP Q1 2026 Earnings EPS Surges Past Estimates with 2972 Beat Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress DJCO Q4 2025 Earnings Strong EPS of 3061 Highlights Profitability Amidst No Revenue Disclosure WKC Q1 2026 Earnings Massive EPS Beat Drives Consideration but Shares Edge Lower Wave Life Sciences WVE Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Pipeline Progress CAC Q1 2026 Earnings EPS Beats Estimates by Nearly 3 Amid Modest Stock Decline